Eterna Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -86 | -69 | 0 | |
EBITDA | -3,965 | -5,460 | -6,808 | -1,133 |
EBIT | -4,009 | -5,546 | -6,877 | -1,203 |
Net Income | -4,009 | -5,506 | -1,502 | -1,240 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,155 | -2,266 | -1,163 | -1,294 |
Cash | 5,028 | 9,177 | 1,884 | 3,047 |
Basic Shares | 1,183 | 792 | 314 | 8,226 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $582 | $68 | $0 |
Gross Profit | -263 | 486 | -168 | -497 |
EBITDA | -13,839 | -36,119 | -19,934 | -24,007 |
EBIT | -14,102 | -37,757 | -21,057 | -24,504 |
Net Income | -14,084 | -44,539 | -21,668 | -24,579 |
Net Change In Cash | 0 | 582 | 68 | 0 |
Free Cash Flow | -7,054 | -16,205 | -20,427 | -21,273 |
Cash | 1,884 | 1,729 | 7,575 | 11,446 |
Basic Shares | 252 | 909 | 354 | 203 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$3.40 |
2026-03-31 | -$6.95 |
2025-12-31 | -$4.80 |
2025-09-30 | -$0.15 |